VEGFA and pancreatic neoplasm: CalebinA significantly inhibited NF-κB p65 activation in both gemcitabine-sensitive and -resistant pancreatic cancer cell lines, accompanied by decreased secretion of angiogenesis-related cytokines VEGF and IL-8, reduced invasive capacity, and impaired tube formation by endothelial cells.